Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Kairos Pharma Ltd (KAPA)

Kairos Pharma Ltd (KAPA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
EF Hutton Provided ‘Buy’ Rating, $9.00 PT in Kairos Pharma (NYSE American: KAPA) Research Report

Kairos Pharma (NYSE American: KAPA), a clinical-stage biopharmaceutical company focused on advancing innovative oncology therapeutics, was featured in an EF Hutton report that initiated coverage with a...

KAPA : 1.7000 (-0.87%)
Kairos Pharma (NYSE American: KAPA) Receives ‘Buy’ Recommendation, $12.00 PT in Rodman & Renshaw Report

Kairos Pharma (NYSE American: KAPA), a clinical-stage biopharmaceutical company focused on advancing innovative oncology therapeutics, is spotlighted today in a Rodman & Renshaw, LLC report that initiated...

KAPA : 1.7000 (-0.87%)
Kairos Pharma to Participate in The Microcap Conference in January 2025

LOS ANGELES, CA / ACCESSWIRE / December 16, 2024 / Kairos Pharma, (NYSE American:KAPA) a clinical stage biotechnology company is pleased to announce its participation in The Microcap Conference 2025, the...

KAPA : 1.7000 (-0.87%)
Kairos Pharma, Ltd. Announces Dual Listing on Upstream to Enhance Global Trading Opportunities

Kairos Pharma, Ltd. gains approval for dual listing on Upstream, enhancing global trading accessibility for investors.Quiver AI SummaryKairos Pharma, Ltd. announced the dual listing of its shares on Upstream,...

KAPA : 1.7000 (-0.87%)
Kairos Pharma Approved to Dual List on Upstream

KAPA : 1.7000 (-0.87%)
10 Stocks/Cryptos With Biggest Increases In Followers On Stocktwits Last Week

Dogecoin, SPY, Bitcoin, Ripple and Innovation Beverage were among the securities that drew retail attention last week.

MARA : 20.15 (+4.68%)
TSLA : 462.28 (+7.36%)
KAPA : 1.7000 (-0.87%)
BTCT : 5.02 (+11.06%)
SPY : 601.30 (+1.11%)
IBG : 1.0800 (+5.88%)
Kairos Pharma to Present at the LD Micro Main Event XVII

KAPA : 1.7000 (-0.87%)
Kairos Pharma to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit

KAPA : 1.7000 (-0.87%)

Barchart Exclusives

Elon Musk's Critical Advice For Growing a Billion Dollar Business: Stop Focusing on Competitors 'It’s Sort of Like the Old Adage of Running'
In a world where businesses obsess over competitive landscapes, Tesla (TSLA) and SpaceX CEO Elon Musk shared a contrarian stance that might actually go against the grain in the world of marketing and growing a business. “I’m not sure looking at competitors really helps. It’s sort of like the old... Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar